Clinical Trials
2 trialsNCT00858754 2019-11-29
Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects
Bausch Health Americas, Inc.
Phase 4 Withdrawn
NCT01004393 2016-02-02
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
University of Vermont
Phase 2 Completed